Browsing by Author "Bor, M"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Non-Synchronized Nasal Intermittent Positive Pressure Ventilation (NIPPV) Versus Nasal Continuous Positive Airway Pressure (NCPAP) After Extubation in Preterm Infants with Respiratory Distress Syndrome
    Ilhan, Ö; Özdemir, SA; Akbay, S; Kanar, B; Memur, S; Bor, M; Özer, EA
    Objective: To determine whether non-synchronized nasal intermittent positive pressure ventilation (NIPPV) reduces the rates of extubation failure, compared to nasal continuous positive airway pressure (NCPAP), in preterm infants with respiratory distress syndrome (RDS). Method: This retrospective study included a total of 49 premature infants who were born at <32 gestational weeks with a birth weight of <1.500 g and required intubation due to RDS. The patients were followed up with NIPPV or NCPAP after extubation. The primary outcome was extubotion failure within 48 hrs of extubotion, while the secondary outcome was neonatal morbidities. Results: A total of 23 patients received NCPAP and 26 patients NIPPV following extubation. Demographic characteristics were similar in both NCPAP and NIPPV groups. Extubation failure was observed in five (21.7%) NCPAP, and in nine (34.6%) NIPPV patients, although any statistically significant intergroup difference was not detected (p=0.32). There were no significant intergroup differences as for post-extubation atelectasis, pneumothorax. Neonatal morbidities and mortality rates. However, the incidence of patent ductus arteriosus was statistically significantly higher in the NIPPV group (p<0.05). In none of the patients gastric or intestinal perforations were observed. Conclusion: It was concluded that NIPPV is not superior to NCPAP performed in preterm infants after extubation in reducing the incidence of reintubation and respiratory morbidities, including pneumothorax and post-extubation atelectasis.
  • No Thumbnail Available
    Item
    Efficacy and Safety of Intravenous Colistin in Very Low Birth Weight Preterm Infants
    Ilhan, O; Bor, M; Ozdemir, SA; Akbay, S; Ozer, EA
    BackgroundGiven the severity and high mortality of multidrug-resistant Gram-negative bacilli (MDR-GNB) infections, the use of colistin will increase in patients with MDR-GNB infection.ObjectiveThis study aims to assess the efficacy and safety of intravenous colistin in very low birth weight (VLBW; birth weight <1500g) preterm infants.MethodsWe retrospectively analyzed the medical records of patients who received colistin between June 2016 and December 2017. The patients were assigned to two groups: the VLBW group and the non-VLBW group. Both groups were evaluated for response to treatment and adverse effects.ResultsIn total, 66 infants who received colistin therapy were included; of these, 28 infants were VLBW. All of our patients received standard colistin treatment of 5mg/kg per day in three doses and the median duration of colistin treatment was 14days. No significant differences were observed between the groups with respect to the efficacy of colistin (defined as showing microbiological clearance in control cultures and the absence of mortality during treatment) (89.3 vs 86.8%, p>0.99). Serum magnesium and potassium levels were significantly lower in the VLBW group than in the non-VLBW group during colistin therapy (magnesium, 1.30 vs 1.70mg/dL, p<0.001; potassium, 3.6 vs 4.6mEq/L, p<0.001). Acute kidney injury was observed in four infants in the VLBW group and one in the non-VLBW group, without significant differences (p=0.15).ConclusionsColistin administration appears to be efficacious in VLBW infants; however, renal function tests and serum electrolytes should be monitored more closely in these infants during treatment.